Complex bacterial infections pre- and posttransplant.

Semin Respir Crit Care Med 2010 Apr 30;31(2):234-42. Epub 2010 Mar 30.

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

Infections complications following lung transplantation are associated with significant morbidity and mortality. Management of infections is most challenging in patients with cystic fibrosis (CF), but all lung transplant recipients are at heightened risk for opportunistic infections. Particularly in CF, pretransplant infections with PSEUDOMONAS AERUGINOSA, other highly resistant bacteria (e.g., STENOTROPHOMONAS, BURKHOLDERIA), and mycobacteria play a major role in recipient selection and post-lung transplant outcomes. Understanding the clinical impact and management strategies for each of these different pathogens is critical to maximizing the benefit of lung transplantation. In the review, we discuss each of these infections both as pretransplant risk factors as well as posttransplant pathogens and the individual issues that arise with each infection.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0030-1249119DOI Listing
April 2010
1 Read

Publication Analysis

Top Keywords

lung transplantation
8
infections pretransplant
8
infections
6
role recipient
4
major role
4
play major
4
recipient selection
4
post-lung transplant
4
outcomes understanding
4
transplant outcomes
4
mycobacteria play
4
selection post-lung
4
stenotrophomonas burkholderia
4
infections pseudomonas
4
pretransplant infections
4
opportunistic infections
4
pseudomonas aeruginosa
4
aeruginosa highly
4
understanding clinical
4
bacteria stenotrophomonas
4

Similar Publications